| Year |
Citation |
Score |
| 2022 |
Nicolaides NC, Makridakis M, Stroggilos R, Lygirou V, Koniari E, Papageorgiou I, Sertedaki A, Zoidakis J, Charmandari E. Plasma Proteomics in Healthy Subjects with Differences in Tissue Glucocorticoid Sensitivity Identifies A Novel Proteomic Signature. Biomedicines. 10. PMID 35052863 DOI: 10.3390/biomedicines10010184 |
0.635 |
|
| 2021 |
Nicolaides NC, Charmandari E. Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update. International Journal of Molecular Sciences. 22. PMID 34639183 DOI: 10.3390/ijms221910839 |
0.674 |
|
| 2021 |
Paltoglou G, Raftopoulou C, Nicolaides NC, Genitsaridi SM, Karampatsou SI, Papadopoulou M, Kassari P, Charmandari E. A Comprehensive, Multidisciplinary, Personalized, Lifestyle Intervention Program Is Associated with Increased Leukocyte Telomere Length in Children and Adolescents with Overweight and Obesity. Nutrients. 13. PMID 34444842 DOI: 10.3390/nu13082682 |
0.635 |
|
| 2021 |
Nicolaides NC, Ioannidi MK, Koniari E, Papageorgiou I, Bartzeliotou A, Sertedaki A, Klapa MI, Charmandari E. Untargeted Plasma Metabolomics Unravels a Metabolic Signature for Tissue Sensitivity to Glucocorticoids in Healthy Subjects: Its Implications in Dietary Planning for a Healthy Lifestyle. Nutrients. 13. PMID 34205537 DOI: 10.3390/nu13062120 |
0.641 |
|
| 2020 |
Tragomalou A, Moschonis G, Kassari P, Papageorgiou I, Genitsaridi SM, Karampatsou S, Manios Y, Charmandari E. A National e-Health Program for the Prevention and Management of Overweight and Obesity in Childhood and Adolescence in Greece. Nutrients. 12. PMID 32961973 DOI: 10.3390/Nu12092858 |
0.323 |
|
| 2020 |
Genitsaridi SM, Giannios C, Karampatsou S, Papageorgiou I, Papadopoulos G, Farakla I, Koui E, Georgiou A, Romas S, Terzioglou E, Papathanasiou C, Kassari P, Manios Y, Charmandari E. A Comprehensive Multidisciplinary Management Plan Is Effective in Reducing the Prevalence of Overweight and Obesity in Childhood and Adolescence. Hormone Research in Paediatrics. 1-14. PMID 32580197 DOI: 10.1159/000507760 |
0.743 |
|
| 2020 |
Tragomalou A, Moschonis G, Manios Y, Kassari P, Ioakimidis I, Diou C, Stefanopoulos L, Lekka E, Maglaveras N, Delopoulos A, Charmandari E. Novel e-Health Applications for the Management of Cardiometabolic Risk Factors in Children and Adolescents in Greece. Nutrients. 12. PMID 32408523 DOI: 10.3390/Nu12051380 |
0.329 |
|
| 2019 |
Genitsaridi SM, Karampatsou S, Papageorgiou I, Mantzou A, Papathanasiou C, Kassari P, Paltoglou G, Kourkouti C, Charmandari E. Hair Cortisol Concentrations in Overweight and Obese Children and Adolescents. Hormone Research in Paediatrics. 1-8. PMID 31851969 DOI: 10.1159/000504913 |
0.309 |
|
| 2019 |
Lamprokostopoulou A, Moschonis G, Manios Y, Critselis E, Nicolaides NC, Stefa A, Koniari E, Gagos S, Charmandari E. Childhood obesity and leukocyte telomere length. European Journal of Clinical Investigation. e13178. PMID 31610015 DOI: 10.1111/Eci.13178 |
0.647 |
|
| 2019 |
Nicolaides NC, Charmandari E. Glucocorticoid Resistance. Experientia Supplementum (2012). 111: 85-102. PMID 31588529 DOI: 10.1007/978-3-030-25905-1_6 |
0.656 |
|
| 2019 |
Nicolaides NC, Polyzos A, Koniari E, Lamprokostopoulou A, Papageorgiou I, Golfinopoulou E, Papathanasiou C, Sertedaki A, Thanos D, Chrousos GP, Charmandari E. Transcriptomics in Tissue Glucocorticoid Sensitivity. European Journal of Clinical Investigation. e13129. PMID 31091335 DOI: 10.1111/Eci.13129 |
0.653 |
|
| 2019 |
Moschonis G, Michalopoulou M, Tsoutsoulopoulou K, Vlachopapadopoulou E, Michalacos S, Charmandari E, Chrousos GP, Manios Y. Assessment of the Effectiveness of a Computerised Decision-Support Tool for Health Professionals for the Prevention and Treatment of Childhood Obesity. Results from a Randomised Controlled Trial. Nutrients. 11. PMID 30917561 DOI: 10.3390/Nu11030706 |
0.306 |
|
| 2018 |
Farakla I, Koui E, Arditi J, Papageorgiou I, Bartzeliotou A, Papadopoulos GE, Mantzou A, Papathanasiou C, Dracopoulou M, Papastamataki M, Moutsatsou P, Papassotiriou I, Chrousos GP, Charmandari E. Effect of Honey on Glucose and Insulin Concentrations in Obese Girls. European Journal of Clinical Investigation. e13042. PMID 30368796 DOI: 10.1111/Eci.13042 |
0.744 |
|
| 2018 |
Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, et al. Research update for articles published in EJCI in 2016. European Journal of Clinical Investigation. e13016. PMID 30099749 DOI: 10.1111/eci.13016 |
0.596 |
|
| 2018 |
Emmanouil CC, Pervanidou P, Charmandari E, Darviri C, Chrousos GP. The effectiveness of a health promotion and stress-management intervention program in a sample of obese children and adolescents. Hormones (Athens, Greece). 17: 405-413. PMID 30099726 DOI: 10.1007/S42000-018-0052-2 |
0.324 |
|
| 2018 |
Kassari P, Papaioannou P, Billiris A, Karanikas H, Eleftheriou S, Thireos E, Manios Y, Chrousos GP, Charmandari E. Electronic registry for the management of childhood obesity in Greece. European Journal of Clinical Investigation. 48. PMID 29327339 DOI: 10.1111/Eci.12887 |
0.317 |
|
| 2017 |
Papageorgiou L, Vlachakis C, Dragoumani K, Raftopoulou S, Brouzas D, Nicolaides NC, Chrousos GP, Charmandari E, Megalooikonomou V, Vlachakis D. HCV genetics and genotypes dictate future antiviral strategies. Journal of Molecular Biochemistry. 6: 33-40. PMID 29387656 |
0.568 |
|
| 2017 |
Al-Daghri NM, Batzel JJ, Burgmann H, Carbone F, Charmandari E, Chrousos GP, Distelmaier K, Cvirn G, Dullaart RPF, Dumitrascu DL, Esteve-Pastor MA, Gervasini G, Goliasch G, Goswami N, Gruppen EG, et al. Research update for articles published in EJCI in 2015. European Journal of Clinical Investigation. 47: 775-788. PMID 28960328 DOI: 10.1111/eci.12819 |
0.558 |
|
| 2017 |
Nicolaides NC, Kino T, Roberts ML, Katsantoni E, Sertedaki A, Moutsatsou P, Psarra AG, Chrousos GP, Charmandari E. The Role of S-Palmitoylation of the Human Glucocorticoid Receptor (hGR) in Mediating the Nongenomic Glucocorticoid Actions. Journal of Molecular Biochemistry. 6: 3-12. PMID 28775968 |
0.607 |
|
| 2017 |
Nicolaides NC, Charmandari E. Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes. Hormones (Athens, Greece). 16: 124-138. PMID 28742501 DOI: 10.14310/Horm.2002.1728 |
0.678 |
|
| 2017 |
Nicolaides NC, Charmandari E, Kino T, Chrousos GP. Stress-Related and Circadian Secretion and Target Tissue Actions of Glucocorticoids: Impact on Health. Frontiers in Endocrinology. 8: 70. PMID 28503165 DOI: 10.3389/Fendo.2017.00070 |
0.664 |
|
| 2017 |
Kyritsi EM, Koltsida G, Farakla I, Papanikolaou A, Critselis E, Mantzou E, Zoumakis E, Kolaitis G, Chrousos GP, Charmandari E. Psychological vulnerability to stress in carriers of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hormones (Athens, Greece). 16: 42-53. PMID 28500827 DOI: 10.14310/Horm.2002.1718 |
0.753 |
|
| 2017 |
Stavrou S, Nicolaides NC, Critselis E, Darviri C, Charmandari E, Chrousos GP. Paediatric stress: from neuroendocrinology to contemporary disorders. European Journal of Clinical Investigation. 47: 262-269. PMID 28074555 DOI: 10.1111/Eci.12724 |
0.654 |
|
| 2016 |
Stavrou S, Nicolaides NC, Papageorgiou I, Papadopoulou P, Terzioglou E, Chrousos GP, Darviri C, Charmandari E. The effectiveness of a stress-management intervention program in the management of overweight and obesity in childhood and adolescence. Journal of Molecular Biochemistry. 5: 63-70. PMID 27570747 |
0.638 |
|
| 2016 |
Nicolaides N, Lamprokostopoulou A, Sertedaki A, Charmandari E. Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance. Hormones (Athens, Greece). 15: 23-34. PMID 27086682 DOI: 10.14310/Horm.2002.1660 |
0.677 |
|
| 2016 |
Nicolaides NC, Skyrla E, Vlachakis D, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E. Functional characterization of the hGRαT556I causing Chrousos syndrome. European Journal of Clinical Investigation. 46: 42-9. PMID 26541474 DOI: 10.1111/Eci.12563 |
0.667 |
|
| 2015 |
Charmandari E, Zhang RG, Silveira LG, Fan QR, Chrousos GP, Sertedaki A, Latronico AC, Segaloff DL. Misfolding Ectodomain Mutations of the Lutropin Receptor Increase Efficacy of Hormone Stimulation. Molecular Endocrinology (Baltimore, Md.). me20151205. PMID 26554443 DOI: 10.1210/Me.2015-1205 |
0.304 |
|
| 2015 |
Nicolaides NC, Lamprokostopoulou A, Polyzos A, Kino T, Katsantoni E, Triantafyllou P, Christophoridis A, Katzos G, Dracopoulou M, Sertedaki A, Chrousos GP, Charmandari E. Transient generalized glucocorticoid hypersensitivity. European Journal of Clinical Investigation. 45: 1306-15. PMID 26479047 DOI: 10.1111/Eci.12554 |
0.67 |
|
| 2015 |
Nicolaides NC, Geer EB, Vlachakis D, Roberts ML, Psarra AM, Moutsatsou P, Sertedaki A, Kossida S, Charmandari E. A novel mutation of the hGR gene causing Chrousos syndrome. European Journal of Clinical Investigation. 45: 782-91. PMID 26031419 DOI: 10.1111/Eci.12470 |
0.662 |
|
| 2015 |
Markou A, Sertedaki A, Kaltsas G, Androulakis I, Marakaki C, Pappa T, Gouli A, Papanastasiou L, Fountoulakis S, Zacharoulis A, Karavidas A, Ragkou D, Charmandari E, Chrousos GP, Piaditis GP. STRESS-INDUCED ALDOSTERONE HYPER-SECRETION IN A SUBSTANTIAL SUBSET OF PATIENTS WITH ESSENTIAL HYPERTENSION. The Journal of Clinical Endocrinology and Metabolism. jc20151268. PMID 25974737 DOI: 10.1210/Jc.2015-1268 |
0.316 |
|
| 2015 |
Nicolaides NC, Charmandari E. Chrousos syndrome: from molecular pathogenesis to therapeutic management. European Journal of Clinical Investigation. 45: 504-14. PMID 25715669 DOI: 10.1111/Eci.12426 |
0.662 |
|
| 2015 |
Hindmarsh PC, Charmandari E. Variation in absorption and half-life of hydrocortisone influence plasma cortisol concentrations. Clinical Endocrinology. 82: 557-61. PMID 25369980 DOI: 10.1111/Cen.12653 |
0.495 |
|
| 2015 |
Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E. Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation. 22: 6-19. PMID 25227402 DOI: 10.1159/000362736 |
0.656 |
|
| 2014 |
Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor. Bmc Endocrine Disorders. 14: 71. PMID 25155432 DOI: 10.1186/1472-6823-14-71 |
0.671 |
|
| 2014 |
Nicolaides NC, Charmandari E, Chrousos GP, Kino T. Circadian endocrine rhythms: the hypothalamic-pituitary-adrenal axis and its actions. Annals of the New York Academy of Sciences. 1318: 71-80. PMID 24890877 DOI: 10.1111/Nyas.12464 |
0.666 |
|
| 2014 |
Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet (London, England). 383: 2152-67. PMID 24503135 DOI: 10.1016/S0140-6736(13)61684-0 |
0.637 |
|
| 2014 |
Nicolaides NC, Roberts ML, Kino T, Braatvedt G, Hurt DE, Katsantoni E, Sertedaki A, Chrousos GP, Charmandari E. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities. The Journal of Clinical Endocrinology and Metabolism. 99: E902-7. PMID 24483153 DOI: 10.1210/Jc.2013-3005 |
0.675 |
|
| 2013 |
Roberts ML, Kino T, Nicolaides NC, Hurt DE, Katsantoni E, Sertedaki A, Komianou F, Kassiou K, Chrousos GP, Charmandari E. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. The Journal of Clinical Endocrinology and Metabolism. 98: E790-5. PMID 23426617 DOI: 10.1210/Jc.2012-3549 |
0.682 |
|
| 2013 |
Charmandari E, Kino T, Chrousos GP. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Endocrine Development. 24: 67-85. PMID 23392096 DOI: 10.1159/000342505 |
0.378 |
|
| 2013 |
Peters CJ, Hill N, Dattani MT, Charmandari E, Matthews DR, Hindmarsh PC. Deconvolution analysis of 24-h serum cortisol profiles informs the amount and distribution of hydrocortisone replacement therapy. Clinical Endocrinology. 78: 347-51. PMID 22803584 DOI: 10.1111/J.1365-2265.2012.04502.X |
0.493 |
|
| 2012 |
Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP. Stress response and child health. Science Signaling. 5: mr1. PMID 23112343 DOI: 10.1126/Scisignal.2003595 |
0.341 |
|
| 2012 |
Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response. Science Signaling. 5: pt5. PMID 23033539 DOI: 10.1126/Scisignal.2003337 |
0.413 |
|
| 2011 |
Charmandari E, Chrousos GP, Lambrou GI, Pavlaki A, Koide H, Ng SS, Kino T. Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. Plos One. 6: e25612. PMID 21980503 DOI: 10.1371/Journal.Pone.0025612 |
0.307 |
|
| 2011 |
Charmandari E. Primary generalized glucocorticoid resistance and hypersensitivity. Hormone Research in Paediatrics. 76: 145-55. PMID 21912096 DOI: 10.1159/000330759 |
0.354 |
|
| 2011 |
Galata Z, Moschonis G, Makridakis M, Dimitraki P, Nicolaides NC, Manios Y, Bartzeliotou A, Chrousos GP, Charmandari E. Plasma proteomic analysis in obese and overweight prepubertal children. European Journal of Clinical Investigation. 41: 1275-83. PMID 21569026 DOI: 10.1111/J.1365-2362.2011.02536.X |
0.649 |
|
| 2010 |
Charmandari E, Kino T. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. European Journal of Clinical Investigation. 40: 932-42. PMID 20649902 DOI: 10.1111/J.1365-2362.2010.02336.X |
0.342 |
|
| 2010 |
Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids. 75: 1-12. PMID 19818358 DOI: 10.1016/J.Steroids.2009.09.002 |
0.66 |
|
| 2009 |
Charmandari E, Chrousos GP, Kino T. Identification of natural human glucocorticoid receptor (hGR) mutations or polymorphisms and their functional consequences at the hormone-receptor interaction level. Methods in Molecular Biology (Clifton, N.J.). 590: 33-60. PMID 19763496 DOI: 10.1007/978-1-60327-378-7_3 |
0.381 |
|
| 2009 |
Chrousos GP, Kino T, Charmandari E. Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence. Neuroimmunomodulation. 16: 272-83. PMID 19571588 DOI: 10.1159/000216185 |
0.382 |
|
| 2008 |
Charmandari E, Ichijo T, Jubiz W, Baid S, Zachman K, Chrousos GP, Kino T. A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. The Journal of Clinical Endocrinology and Metabolism. 93: 4963-8. PMID 18827003 DOI: 10.1210/Jc.2008-0892 |
0.316 |
|
| 2008 |
Charmandari E, Kino T, Ichijo T, Chrousos GP. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. The Journal of Clinical Endocrinology and Metabolism. 93: 1563-72. PMID 18319312 DOI: 10.1210/Jc.2008-0040 |
0.303 |
|
| 2007 |
Charmandari E, Kino T, Ichijo T, Jubiz W, Mejia L, Zachman K, Chrousos GP. A novel point mutation in helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. The Journal of Clinical Endocrinology and Metabolism. 92: 3986-90. PMID 17635946 DOI: 10.1210/Jc.2006-2830 |
0.383 |
|
| 2007 |
Charmandari E, Kino T. Novel causes of generalized glucocorticoid resistance. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 39: 445-50. PMID 17578762 DOI: 10.1055/S-2007-980196 |
0.402 |
|
| 2006 |
Charmandari E, Chrousos GP. Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? Annals of the New York Academy of Sciences. 1083: 37-53. PMID 17148732 DOI: 10.1196/Annals.1367.005 |
0.377 |
|
| 2006 |
Kino T, Souvatzoglou E, Charmandari E, Ichijo T, Driggers P, Mayers C, Alatsatianos A, Manoli I, Westphal H, Chrousos GP, Segars JH. Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. The Journal of Biological Chemistry. 281: 9118-26. PMID 16469733 DOI: 10.1074/Jbc.M509339200 |
0.308 |
|
| 2006 |
Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance. The Journal of Clinical Endocrinology and Metabolism. 91: 1535-43. PMID 16449337 DOI: 10.1210/Jc.2005-1893 |
0.334 |
|
| 2005 |
Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity. The Journal of Clinical Endocrinology and Metabolism. 90: 3696-705. PMID 15769988 DOI: 10.1210/Jc.2004-1920 |
0.353 |
|
| 2005 |
Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Annual Review of Physiology. 67: 259-84. PMID 15709959 DOI: 10.1146/Annurev.Physiol.67.040403.120816 |
0.341 |
|
| 2005 |
Charmandari E, Chrousos GP, Merke DP. Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency. Journal of Pediatric Endocrinology & Metabolism : Jpem. 18: 97-101. PMID 15679075 DOI: 10.1515/Jpem.2005.18.1.97 |
0.346 |
|
| 2004 |
Kino T, Liou SH, Charmandari E, Chrousos GP. Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function. Molecular Medicine (Cambridge, Mass.). 10: 80-8. PMID 16307173 DOI: 10.2119/2005-00026.Kino |
0.316 |
|
| 2004 |
Charmandari E, Brook CG, Hindmarsh PC. Classic congenital adrenal hyperplasia and puberty. European Journal of Endocrinology. 151: U77-82. PMID 15554890 DOI: 10.1530/Eje.0.151U077 |
0.754 |
|
| 2004 |
Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms. Annals of the New York Academy of Sciences. 1024: 168-81. PMID 15265781 DOI: 10.1196/Annals.1321.014 |
0.373 |
|
| 2004 |
Charmandari E, Merke DP, Negro PJ, Keil MF, Martinez PE, Haim A, Gold PW, Chrousos GP. Endocrinologic and psychologic evaluation of 21-hydroxylase deficiency carriers and matched normal subjects: evidence for physical and/or psychologic vulnerability to stress. The Journal of Clinical Endocrinology and Metabolism. 89: 2228-36. PMID 15126546 DOI: 10.1210/Jc.2003-031322 |
0.346 |
|
| 2004 |
Charmandari E, Kino T, Souvatzoglou E, Vottero A, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype. The Journal of Clinical Endocrinology and Metabolism. 89: 1939-49. PMID 15070967 DOI: 10.1210/Jc.2003-030450 |
0.345 |
|
| 2004 |
Weise M, Mehlinger SL, Drinkard B, Rawson E, Charmandari E, Hiroi M, Eisenhofer G, Yanovski JA, Chrousos GP, Merke DP. Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise. The Journal of Clinical Endocrinology and Metabolism. 89: 591-7. PMID 14764767 DOI: 10.1210/Jc.2003-030634 |
0.302 |
|
| 2003 |
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Sexual dimorphism in the synchrony of joint growth hormone and cortisol dynamics in children with classic 21-hydroxylase deficiency Journal of Pediatric Endocrinology and Metabolism. 16: 1119-1130. PMID 14594172 DOI: 10.1515/Jpem.2003.16.8.1119 |
0.503 |
|
| 2003 |
Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes Journal of Steroid Biochemistry and Molecular Biology. 85: 457-467. PMID 12943736 DOI: 10.1016/S0960-0760(03)00218-8 |
0.372 |
|
| 2003 |
Roche EF, Charmandari E, Dattani MT, Hindmarsh PC. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report. Clinical Endocrinology. 58: 589-96. PMID 12699440 DOI: 10.1046/J.1365-2265.2003.01757.X |
0.563 |
|
| 2003 |
Charmandari E, Kino T, Souvatzoglou E, Chrousos GP. Pediatric stress: hormonal mediators and human development. Hormone Research. 59: 161-79. PMID 12649570 DOI: 10.1159/000069325 |
0.395 |
|
| 2002 |
Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension. Annals of the New York Academy of Sciences. 970: 101-11. PMID 12381545 DOI: 10.1111/J.1749-6632.2002.Tb04416.X |
0.385 |
|
| 2002 |
Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism. 87: 3197-200. PMID 12107224 DOI: 10.1210/Jcem.87.7.8652 |
0.319 |
|
| 2002 |
Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia. Journal of Pediatric Endocrinology & Metabolism : Jpem. 15: 435-9. PMID 12008691 DOI: 10.1515/Jpem.2002.15.4.435 |
0.728 |
|
| 2002 |
Charmandari E, Pincus SM, Matthews DR, Johnston A, Brook CG, Hindmarsh PC. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion. The Journal of Clinical Endocrinology and Metabolism. 87: 2238-44. PMID 11994370 DOI: 10.1210/Jcem.87.5.8503 |
0.737 |
|
| 2002 |
Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. The Journal of Clinical Endocrinology and Metabolism. 87: 2114-20. PMID 11994350 DOI: 10.1210/Jcem.87.5.8456 |
0.361 |
|
| 2002 |
Charmandari E, Brook CG, Hindmarsh PC. Why is management of patients with classical congenital adrenal hyperplasia more difficult at puberty? Archives of Disease in Childhood. 86: 266-9. PMID 11919101 DOI: 10.1136/Adc.86.4.266 |
0.745 |
|
| 2002 |
Charmandari E, Dattani MT, Perry LA, Hindmarsh PC, Brook CG. Kinetics and effect of percutaneous administration of dihydrotestosterone in children. Hormone Research. 56: 177-81. PMID 11910204 DOI: 10.1159/000048115 |
0.696 |
|
| 2001 |
Charmandari E, Matthews DR, Johnston A, Brook CGD, Hindmarsh PC. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: Is current replacement therapy satisfactory? Journal of Clinical Endocrinology and Metabolism. 86: 4679-4685. PMID 11600525 DOI: 10.1210/Jcem.86.10.7972 |
0.511 |
|
| 2001 |
Charmandari E, Pincus SM, Matthews DR, Dennison E, Fall CHD, Hindmarsh PC. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts Journal of Clinical Endocrinology and Metabolism. 86: 3393-3399. PMID 11443216 DOI: 10.1210/Jcem.86.7.7695 |
0.512 |
|
| 2001 |
Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG. Congenital adrenal hyperplasia: management during critical illness. Archives of Disease in Childhood. 85: 26-8. PMID 11420193 DOI: 10.1136/Adc.85.1.26 |
0.496 |
|
| 2001 |
Charmandari E, Hindmarsh PC, Johnston A, Brook CG. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. The Journal of Clinical Endocrinology and Metabolism. 86: 2701-8. PMID 11397874 DOI: 10.1210/Jcem.86.6.7522 |
0.721 |
|
| 2001 |
Charmandari E, Johnston A, Brook CG, Hindmarsh PC. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. The Journal of Endocrinology. 169: 65-70. PMID 11250647 DOI: 10.1677/Joe.0.1690065 |
0.488 |
|
| 2000 |
Koziell A, Charmandari E, Hindmarsh PC, Rees L, Scambler P, Brook CG. Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? Clinical Endocrinology. 52: 519-24. PMID 10762296 DOI: 10.1046/J.1365-2265.2000.052006801.X |
0.524 |
|
| Show low-probability matches. |
